Clinical Therapeutics: the international peer-reviewed journal of drug therapy

Journal

Publication Venue For

  • Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination.  44:982-997.e2. 2022
  • Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.  42:e259-e274. 2020
  • Erratum to “Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture” [Clin Therapeut 42 (6) (2020) 1099–1107] (Clinical Therapeutics (2020) 42(6) (1099–1107.e1), (S0149291820301995), (10.1016/j.clinthera.2020.04.012)).  42:2117. 2020
  • Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture.  42:1099-1107.e1. 2020
  • Antiviral Therapies for Herpesviruses: Current Agents and New Directions.  40:1282-1298. 2018
  • Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities.  40:1255-1267. 2018
  • Gender Differences in Pain Experience and Treatment after Motor Vehicle Collisions: A Secondary Analysis of the CRASH Injury Study.  40:204-213.e2. 2018
  • Getting the Brain Into Shape: Exercise in Neurological Disorders.  40:6-7. 2018
  • Role of Physical Activity and Exercise in Alleviating Cognitive Impairment in People With Epilepsy.  40:26-34. 2018
  • Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor–Alpha Experienced Rheumatoid Arthritis.  39:1680-1694.e2. 2017
  • Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac.  38:2418-2429. 2016
  • Differences in the Association of Nocturia and Functional Outcomes of Sleep by Age and Gender: A Cross-sectional, Population-based Study.  38:2386-2393.e1. 2016
  • Erratum: Corrigendum to “Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases” (Clinical Therapeutics (2016) 38(6) (1451–1463)(S0149291816301849)(10.1016/j.clinthera.2016.03.038)).  38:2506-2507. 2016
  • Pilot Results from a Randomized Trial in Men Comparing Alpha-Adrenergic Antagonist versus Behavior and Exercise for Nocturia and Sleep.  38:2394-2406.e3. 2016
  • Initial Experience with Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination with Conventional Synthetic DMARDs in 2 US Health Care Claims Databases.  38:1451-1463. 2016
  • Postanesthesia Care for the Elderly Patient.  37:2651-2665. 2015
  • Estimating effectiveness and cost of biologics for rheumatoid arthritis: Application of a validated algorithm to commercial insurance claims.  36:996-1004. 2014
  • Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: Meta-regression based on two systematic literature reviews.  36:906-917. 2014
  • Update on vaccination clinical trials for HPV-related disease.  36:8-16. 2014
  • Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.  35. 2013
  • Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States.  34:1966-1976. 2012
  • Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor.  34. 2012
  • Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care.  33:679-707. 2011
  • Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.  33:393-407. 2011
  • The natural history of fabry disease.  32. 2010
  • Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.  32:1252-1269. 2010
  • Enzyme Replacement Therapy and Fabry Kidney Disease.  29. 2007
  • Analgesia and anesthesia for neonates: Study design and ethical issues.  27:814-843. 2005
  • Long-Term Safety and Efficacy of the Selective Aldosterone Blocker Eplerenone in Patients with Essential Hypertension.  25:2388-2404. 2003
  • An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.  20:398-409. 1998
  • An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators..  20:398-409. 1998
  • Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker.  20:1106-1114. 1998
  • The expanding role of calcium antagonists in cardiovascular disease.  19:1-2. 1997
  • Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.  18:608-625. 1996
  • The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension.  18:797-810. 1996
  • The role of sertraline in the management of depression.  16:768-782. 1994
  • Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas.  15:46-56. 1993
  • Reversal of central nervous system effects by flumazenil after intravenous conscious sedation with midazolam: Report of a multicenter clinical study.  14:861-877. 1992
  • Efficacy of a premixed semisynthetic human insulin regimen.  11:795-801. 1989
  • International Standard Serial Number (issn)

  • 0149-2918
  • Electronic International Standard Serial Number (eissn)

  • 1879-114X